Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

SWX:KURN
SWX:KURNBiotechs

European Growth Companies With High Insider Ownership

As the pan-European STOXX Europe 600 Index and major single-country stock indexes continue to rise, investors are keeping a close eye on inflation trends that suggest eurozone inflation could remain near the European Central Bank's target. In this environment, growth companies with high insider ownership may capture attention due to their potential for aligning management interests with shareholder value, making them an intriguing focus for those navigating Europe's evolving market landscape.
BIT:CYB
BIT:CYBIT

European Penny Stocks: Cyberoo And 2 Other Noteworthy Picks

As European markets experience a notable upswing, with the STOXX Europe 600 Index rising by 2.35% and major country indexes following suit, investor interest in smaller-cap opportunities has been piqued. The term 'penny stocks' might feel like a relic of past market eras, but the potential they represent is as real as ever. These smaller or newer companies, when built on solid financials, can lead to significant returns; we've selected three examples of penny stocks that combine balance sheet...
WSE:MNC
WSE:MNCLeisure

Top European Dividend Stocks For December 2025

As European markets continue to show resilience, with the STOXX Europe 600 Index climbing 2.35% and major single-country indexes also posting gains, investors are increasingly focusing on dividend stocks as a means to generate steady income amidst economic uncertainties. In this context, selecting dividend stocks that demonstrate consistent payouts and align with broader market stability can provide a reliable income stream while navigating fluctuating economic conditions.
NYSE:UNFI
NYSE:UNFIConsumer Retailing

United Natural Foods (UNFI) Narrows Q1 Losses, Testing Bullish Turnaround Narratives

United Natural Foods (UNFI) opened fiscal Q1 2026 with revenue of about $7.8 billion and a basic EPS loss of roughly $0.07, alongside a trailing 12 month EPS of around negative $1.67 and net income of negative $101 million, keeping the bottom line in the red despite steady sales. The company has seen quarterly revenue move from $7.9 billion in Q1 2025 to $7.8 billion in Q1 2026, while basic EPS losses narrowed from about $0.35 a year ago and sat against a trailing 12 month revenue base of...
NasdaqGS:KURA
NasdaqGS:KURABiotechs

Kura Oncology (KURA) Is Down 7.2% After First KOMZIFTI Sale Triggers $135M Milestone Payment

Kura Oncology recently reported that it completed the first U.S. commercial sale of KOMZIFTI (ziftomenib), its newly FDA-approved oral menin inhibitor for adults with relapsed or refractory NPM1‑mutated acute myeloid leukemia, which also triggered a US$135,000,000 milestone payment from partner Kyowa Kirin expected before year-end 2025. This first sale, combined with KOMZIFTI’s inclusion in NCCN guidelines as a Category 2A recommended option, signals early clinical acceptance and provides an...
NasdaqGM:MDB
NasdaqGM:MDBIT

MongoDB (MDB) Q3: Losses Narrow Sharply, Testing Bullish Profitability Narratives

MongoDB (MDB) has just posted its Q3 2026 numbers, with revenue of about $628.3 million and basic EPS of roughly -$0.02, alongside net income excluding extra items of approximately -$2.0 million, marking another quarter where growth and profitability are still in tension. The company has seen quarterly revenue move from around $478.1 million in Q2 2025 to $628.3 million in Q3 2026. Basic EPS has swung between about -$0.74 and a brief positive patch of roughly $0.20 before landing at -$0.02...